Mechanisms of tumor suppression by the SCFFbw7

被引:104
作者
Minella, AC
Clurman, BE
机构
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA
[3] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
关键词
cell cycle; cyclin E; ubiquitination; Fbw7; SCF complex; tumorigenesis; Ras;
D O I
10.4161/cc.4.10.2058
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
SCF ubiquitin ligases regulate the degradation of many proteins involved in the control of cell division and growth. F-box proteins are the SCF components that bind to substrates, and this binding is usually signaled by substrate phosphorylation. The Fbw7/hCdc4 F-box protein was first recognized by its ability to bind cyclin E, and the SCFFbw7 is now known to target c-Myc, c-Jun and Notch for degradation in addition to its role in cyclin E proteolysis. Fbw7 thus negatively regulates several key oncoproteins. Accordingly, Fbw7 is a tumor suppressor that is mutated in a wide spectrum of human cancers, and Fbw7 functions as a haploinsufficient tumor suppressor in mice. Because there are three Fbw7 isoforms that reside in different subcellular compartments, as well as multiple Fbw7 substrates that are the products of proto-oncogenes, the mechanisms of tumor suppression by Fbw7 are complex and incompletely understood. In this review we discuss the activities of the SCFFbw7 in the context of its role as a tumor suppressor and highlight recent findings demonstrating that dominant oncogenes disable Fbw7 function.
引用
收藏
页码:1356 / 1359
页数:4
相关论文
共 62 条
[1]   SCF-mediated protein degradation and cell cycle control [J].
Ang, XLL ;
Harper, JW .
ONCOGENE, 2005, 24 (17) :2860-2870
[2]   c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover [J].
Bahram, F ;
von der Lehr, N ;
Cetinkaya, C ;
Larsson, LG .
BLOOD, 2000, 95 (06) :2104-2110
[3]   SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box [J].
Bai, C ;
Sen, P ;
Hofmann, K ;
Ma, L ;
Goebl, M ;
Harper, JW ;
Elledge, SJ .
CELL, 1996, 86 (02) :263-274
[4]  
BHATIA K, 1994, BLOOD, V84, P883
[5]   POINT MUTATIONS IN THE C-MYC TRANSACTIVATION DOMAIN ARE COMMON IN BURKITTS-LYMPHOMA AND MOUSE PLASMACYTOMAS [J].
BHATIA, K ;
HUPPI, K ;
SPANGLER, G ;
SIWARSKI, D ;
IYER, R ;
MAGRATH, I .
NATURE GENETICS, 1993, 5 (01) :56-61
[6]   Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E [J].
Bortner, DM ;
Rosenberg, MP .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (01) :453-459
[7]   Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation [J].
Clurman, BE ;
Sheaff, RJ ;
Thress, K ;
Groudine, M ;
Roberts, JM .
GENES & DEVELOPMENT, 1996, 10 (16) :1979-1990
[8]   Deregulation of cyclin E in human cells interferes with prereplication complex assembly [J].
Ekholm-Reed, S ;
Méndez, J ;
Tedesco, D ;
Zetterberg, A ;
Stillman, B ;
Reed, SI .
JOURNAL OF CELL BIOLOGY, 2004, 165 (06) :789-800
[9]   A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p [J].
Feldman, RMR ;
Correll, CC ;
Kaplan, KB ;
Deshaies, RJ .
CELL, 1997, 91 (02) :221-230
[10]   Mastermind recruits CycC:CDK8 to phosphorylate the notch ICD and coordinate activation with turnover [J].
Fryer, CJ ;
White, JB ;
Jones, KA .
MOLECULAR CELL, 2004, 16 (04) :509-520